Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.

British journal of haematology - 1 Feb 2012

Vercauteren Suzanne M, Starczynowski Daniel T, Sung Sandy, McNeil Kelly, Salski Chris, Jensen Clara-Lynn, Bruyere Helene, Lam Wan L, Karsan Aly

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Bone Marrow Cells
Share to Cell Transformation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Aberrations

Share to Clonal Evolution

Share to Comparative Genomic Hybridization

Share to In Situ Hybridization, Fluorescence

Share to Myelodysplastic Syndromes

Source

Open in PubMed Open full text

Identifiers

PMID: 25289412
DOI: 10.1111/j.1365-2141.2011.08872.x
PMCID: PMC4191868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.PMID 25289412Read ↗

Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4+ subset and oligoclonal in the CD8+ subsetSemantic proximity Read ↗

[Myelodysplastic syndromes: mechanisms of transformation and neoplastic progression and their clinical implications].Semantic proximity Read ↗

Biology and pathogenesis of the myelodysplastic syndromes.Semantic proximity Read ↗

Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromesSemantic proximity Read ↗

[Pathogenesis of myelodysplastic syndromes].Semantic proximity Read ↗

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic SyndromeSemantic proximity Read ↗

The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: An in vitro studySemantic proximity Read ↗

Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromesSemantic proximity Read ↗

Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic SyndromeSemantic proximity Read ↗

New Subtype Proposed for Myelodysplastic Syndrome.Semantic proximity Read ↗

Stem cell origin of myelodysplastic syndromesSemantic proximity Read ↗

Characteristics of macrophages from myelodysplastic syndrome microenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.